NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Genomics & Genetics Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Arthritis



Researchers from Tokushima Bunri University publish new studies and findings in the area of arthritis



December 12th, 2008

"While inflammatory cytokines are well-recognized critical factors for the induction of cyclooxygenase-2 (COX-2) in activated fibroblast-like synovial cells, the roles of biologically active components other than inflammatory cytokines in synovial fluid remain unknown. Herein, we assessed the role of lysophosphatidic acid (LPA), a pleiotropic lipid mediator, in COX-2 induction using synovial fluid of patients with rheumatoid arthritis (RA) in fibroblast-like RA synovial cells," scientists writing in the Journal of Immunology report.

"Synovial fluid from RA patients stimulated COX-2 induction, which was associated with prostaglandin E, production, in RA synovial...


Source: Genomics & Genetics Weekly (2008-12-12)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login